Cellebrite DI Ltd. (CLBT)

$13.69

up-down-arrow $0.05 (0.37%)

As on 05-May-2026 14:37EDT

Market cap

info icon

$3,330 Mln

Revenue (TTM)

info icon

$476 Mln

P/E Ratio

info icon

43.1

P/B Ratio

info icon

6.9

Div. Yield

info icon

0 %

Value Research Rating

--

Quality Score fund-quick-summary-circle

0/0

Growth Score fund-quick-summary-circle

0/0

Valuation Score fund-quick-summary-circle

0/0

Momentum Score fund-quick-summary-circle

0/0

Cellebrite DI (CLBT) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 13.42 High: 13.73

52 Week Range

Low: 11.02 High: 20.45

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    0.2 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    28.3

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $1.9

  • EPSEPS information

    $0.3

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    249,439,817

5 Years Aggregate

CFO

$241.33 Mln

EBITDA

$92.73 Mln

Net Profit

$115.01 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Cellebrite DI (CLBT)
-24.1 -2.2 -1.9 -32.0 36.3 6.7 --
BSE Sensex
-9.0 5.0 -8.1 -4.3 7.6 9.8 11.9
As on 05-May-2026
Company
2025
2023
2022
2021
Cellebrite DI (CLBT)
-18.2 98.6 -45.6 -23.8
BSE Sensex
9.1 18.7 4.4 22.0
BSE Sensex
9.1 18.7 4.4 22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Cellebrite DI (CLBT)

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review,...  extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel. Address: 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602  Read more

  • Founder, CEO & Director

    Mr. Yossi Carmil

  • CEO & Director

    Mr. Thomas E. Hogan

  • Headquarters

    Petah Tikva

  • Website

    https://www.cellebrite.com

Edit peer-selector-edit
loading...
loading...

FAQs for Cellebrite DI (CLBT)

The share price of Cellebrite DI Ltd (CLBT) is $13.69 (NASDAQ) as of 05-May-2026 14:37 EDT. Cellebrite DI Ltd (CLBT) has given a return of 36.27% in the last 3 years.

The P/E ratio of Cellebrite DI Ltd (CLBT) is 43.06 times as on 04-May-2026.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
57.89
9.36
2024
-19.25
16.22
2023
-20.76
49.22
2022
6.96
11.38
2021
22.36
-21.77

The 52-week high and low of Cellebrite DI Ltd (CLBT) are Rs 20.45 and Rs 11.02 as of 06-May-2026.

Cellebrite DI Ltd (CLBT) has a market capitalisation of $ 3,330 Mln as on 04-May-2026. As per SEBI classification, it is a company.

Before investing in Cellebrite DI Ltd (CLBT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.